A B S T R A C T The net renal metabolism of amino acids and ammonia in the post absorptive state was evaluated in subjects with normal renal functioin and in patients with chronic renal insufficiency by measuring renal uptake and release, and urinary excretion of free amino acids and ammonia. In normial subjects the kidney extracts glutamine, proline, citrulline, and phenylalanine and releases serine, arginine, taurine, threonine, tyrosine, ornithine, lysine, and perhaps alanine. The renal uptake of amino acids from arterial blood occurs by way of plasma only, whereas approximately a half of amino acid release takes place by way of blood cells. Glycine is taken up from arterial plasma, while similar amounts of this amino acid are released by way of blood cells. In the same subjects total renal ammonia production can be largely accounted for by glutamine extracted.
INTRODUCTION
In normal mammals in the post absorptive state the kidney seemns to play a substantial metabolic role for a limited number of amino acids (AA).' It is well known that this organ is an important site for the disposal of glutamine, which is used mainly for the production of ammonia, the most important buffer for strong acid excretion (1) . In addition, the kidney is the almost exclusive site for the synthesis of serine (2, 3) which, at least in part, could derive from glycine extracted from the arterial blood (3) . Finally, the kidney seems to release alanine and cysteine (2, 4) . Whether chronic renal insufficiency (CRI) induces alterations in the net metabolism of some AA across the kidney is obscure. The only available data show that, in this clinical status, patients with still relatively high glomerular filtration rates (GFR) and ammnonia production have a negligible renal extraction of glutamine from arterial plasma, certainly not sufficient to account for ammonia produced (5) . On the other hand, there is no information on alternative precursors uised by the kidney for ammonia formation in this condition.
Studies presented in this report were designed to evaluate the net AA and ammonia metabolism across the kidney in subjects with normal renal function and in patients with CRI. The study was performed by measuring renal uptake or release and urinary excretion of AA and ammonia. Considering the role of blood cells in the exchange of AA across many organs (6) , AA determinations were carried out both on whole blood and plasma.
METHODS
Patients. Two groups of patients were studied and are described in Table I . The first group had arterial hypertension i Abbreviations used in this paper: AA, amino acids; A-RV, arterial-renal venous; CRI, chronic renal insufficiency; GFR. glomerular filtration rate; Hct, hematocrit; PAH, Na paraaminohippurate. 
MI
with mean blood pressures ranging from 133 to 160 mm Hg. Routine hematological tests, serum, and urine electrolyte concentrations, acid-base measurements, urinalysis, and renal f'tunction tests were normal. The rapid seqtuence intravenouis pyelography showed a unilateral delayed appearance time of the contrast material and a persistent hyperconcentration of it. However, no significant difference in renal size was present. The second grouip consisted of five patients with CR1.A mild azotemia had been present froml 3 mo to 3 y. All patienlts were in good niutritional balance and xwere actively employed at the timile ofthe study. They had no history or evideute of congestive heart foailuire, pulmonary, or hepatic diseatses or diabetes inellitus. Seruim sodituim and potassiumil were in the normnal range. Proteinuria was lower thaini 0.5 g/24 h iii four patienits and was 1 g/24 h in one patient (C.A.). Urine eultiures were rep)eatedly negative. All patients were on a diet strictly coillparable with that assulmed by the control grotil). Two patients (L.I. and T.P.) had severe hypertension and elevated reninl plasina activity, so that a renal vein cathelteriza.tion for renin attivity deteriiination was useful for diagnostic purposes. The other three patients showed bone alterationis that were mnore severe than could be exl)ected on the basis of degree and duirattion of their renal insufficiency and that were attributed to hyperparathyroidism. Innominate, internal juigular anid thyroid veins cathieterizatioin for parathonisonie measuirements was carried out to localize the hyperfunctioninig parathyroid tissule, in view of a possible parathyroidectomy. In the patients xwith severe hypertension, the intravenous pyelographv showed at uinilateral delayed appearance time and a persistent hyperconicentration of the contrast material. In all five patients the renal size was norimial or slightly reduced withiotit any uinilateral disparity in renal ma.ss.
Patients of both groups were informed of the naittire, pur- Calciulations. Renal arterial plasma flow was calcuilated from clearance and extraction of PAH using the equation of Wolf (13) . Renal arterial blood flow was calculated from renal p)lasma flow and arterial Het. Renal blood cell flow vas obtainied by subtracting plasma flow from blood flow.
The levels of AA and ammonia in whole blood and of AA in plasma was calcuilated using a dilution factor corresponding to the dilution of the sample after deproteination and neutralization. A water content of 80 and 93%, respectively for whole blood and plasma was taken into accouint for the calculation of the diluition factor (14) . The levels of AA in blood cells were calcullated by the following formula (15) = level of AA in plasma (,mmol/liter). The coefficients of variation for individual AA analyses wvere: +2% for glutamine; +3% for glutamate, leucine, tyrosine, phenylalanine, and 3-methylhistidine; ±4% for aspartate, glycine, alanine, valine, methionine, citrulline, and arginine; ±5% for serine, isoleucine, ornithine, lysine, and histidine; ±+-7% for threonine and proline; and ±+9% for a-amninobutyric acid.
Net Controls and patients with CRI were compared by analysis of variance by using a completely randomized design. A randomized block design was applied to the analysis of variance for the paired data. This method was followed to ascertain if the A-RV differences were significantly different from zero. Relationships between citrulline uptake and arginine release and l)etween arterial level ofeach individuial AA and their renal release or uptake were sttudied by analysis of linear regression and correlation (16) . Values are given as mean+1 SENM.
RESULTS
A-RV differences and net balance across the kidney offree AA in whole blood, plasina and blood cells in ssubjects with normal rencal function acnd in patients wiith CR1. In normal subjects (Table II) AA determinations in whole blood show significant positive A-RV differences only for glutamine, proline, citrulline and phenylalanine, indicating a renal uptake of these AA. The rate of glutamine uptake accounts for 58% of the total AA extraction by the kidney. In the same subjects, analysis of plasma demonstrates a significant uptake of glycine also. Since the rates of glutamine, proline, citrulline, and phenylalanine uptakes are strictly comparable both in whole blood and in plasma, it follows that the kidney takes up these AA only from arterial plasma. Conversely, in the case of glycine, which is extracted from plasma but not from whole blood, blood cells must play an important role in the exchange of this AA across the kidney.
A-RV differences determined in whole blood are negative for taurine, threonine, serine, tyrosine, ornithine, lysine, and arginine, indicating a release into the circulation of these AA. The release of alanine is only at the borderline of significance (P < 0.1), likely depending on a high variability among subjects. The rate of serine release is responsible for 37% of the total AA output by the kidney. In the same subjects serine and omithine are released into the renal venous blood only by way of plasma; taurine, threonine, and lysine only by way of blood cells. Alanine, tyrosine, and arginine are added to the renal veins both by way of plasma and blood cells.
In patients with CRI (Table III) AA analyses both on whole blood and on plasma demonstrate a significant decrease in renal extraction of glutamine, proline, and citrulline in comparison with controls. As in normal subjects, these AA are extracted by the kidney only from arterial plasma. Phenylalanine extraction is not detectable. Glycine uptake from plasma and glycine release by way ofblood cells disappear completely. In patients with CRI, as in normal subjects, A-RV differences on whole blood are negative for threonine, serine, alanine, tyrosine, lysine, and arginine, indicating a release of these AA. However the rates of release of these AA are variously decreased. The comparison between the rate of release obtained from whole blood and from plasma measurements indicate that these AA are released into renal venous blood via plasma only. Consequently, in contrast to normal controls, in CRI no role is played by blood cells in such exchange. Again in contrast to controls, taurine and ornithine release disappears, whereas a statistically detectable output of leucine occurs.
In patients with CRI there are increases in whole Amino Acid and Ammonia Metabolism by Normal and Diseased Kidney blood arterial level of 3-methylhistidine, proline (P < 0.01), citrulline (P < 0.001), histidine (P < 0.005), and perhaps glutamine (P < 0.1) and phenylalanine (P < 0.1), whereas there are decreases of aspartate (P < 0.005), tyrosine (P < 0.005), and perhaps serine (P < 0.1) and lysine (P < 0.1). Excretion of most urinary AA was negligible in both normal and pathological conditions. Differences in urinary output at the borderline of significance (P < 0.1) are observed only for 3-methylhistidine, which is excreted in lower amount in CRI, and for proline, which, coinversely, is excreted in higher amount. Table IV gives the rates of renal AA extraction and release per 100 ml of GFR. It is evident that the extraction of citrulline and the release of alanine, leucine, tyrosine, and arginine appear markedly increased, whereas the extraction of glutamine and proline, and the release of threonine, seriine and lysine are unchanged in compariso°n /with normiial controls. Fig. 1 depicts the relationship between citrulline extraction and arginine release in subjects with normal renal function and in patients with CRI. A highly significant direct linear correlation was observed (P < 0.001). Fig. 2 shows the relationship between the release into the renal veins of tyrosine and the arterial level of the same AA in subjects with normal renal function and in patients with CRI. A significant correlation was found (P < 0.05). No significant correlation between the arterial level of other AA and their renal metabolism was observed.
Renal anmmonia production in subjects with normal renal function and in patients w;ith CRI. In normal subjects total renal amimonia production was 37.8+3.08 ,umol/min, almost e(qually partitioned between urine and renal venous blood (Table V) . Both urinary ammonia and ammonial added to the renal venous blood are reduced in patienits with CRI. Consequenitly, total renal ammiionia production is decreased. If total amilmonia production is expressed per 100 ml of GFR, the rate of ammonia production per unit of GFR is much greater in patients with CRI than in subjects with normal renal function. The distribution of ammonia produced between urine and renal venous blood is not different from normal controls and this finding is likely dependent on strictly comparable urinary pH and flow.
Nitrogen extraction and release by the kidney in subjects twith normal retnalfutnction and in patients with CRI (Table VI) . In normal conditions N contribuited by AA extracted, and N contributed by AA and ammonia released by the kidney are well balanced. On the contrary, patients with CRI shiow a 140% excess of N added to the renal venous blood (P < 0.025).
DISCUSSION
Findings presented here confirm previous observation by Owen and Robinson (2) demonstrating that in normal conditions the htuman kidney extracts glutamine and proline and releases large amounts of serine into the renial veins. Our data provide stronger statistical evidence for the release ofarginine. Alanine outptut is at the borderline of statistical significance in our study, whereas it is statistically signiificant in Owen acnd Robinson's normial sul)jects. On the contrary, this AA is significanitly extracted by the kidney in starved imlan (17) . In addition, wve obtained several new resuilts. A signiificant citrulline and pheniylalanine extraction and a talirine, threonine, lysine, tyrosine, and ornithine release are observed. The detection ofthe renal release of a greater nulmber of AA in compparison with data by Owen and Robinson is partly due to the important role played by 1)lood cells in the halnidling of AA by the kidney. For the samlle reatson, the net balance of glycine aceross the kidnev is not differenit fromn zero.
The data presenite(d here (lemonstrate that renal uptake of AA fromn arterial blood occurs by way of plasmiia onlv, whereas AA release by the kidney to renal venouis ,with normal traction of other AA and that the extraction rate of gluits with CRI tamine is related to the acid-base status of the subjects, since glutamine is the major precursor used by the kidney for ammonia formation (1) . The values of renal glutamine uptake in normal subjects studied here by analTay of blood yses on whole blood confirm previous results obtained (Table II) . In normal conditions the amount sma and via of glutamine extracted from blood is sufficient to acy, glycine is count for all the ammonia produced. The ratio of amma and de-monia production to glutamine extraction is -1, and this suggests that only a half of N provided by this AA is used for ammonia synthesis, the other half likely ,. @ es ) being added to an intrarenal N pool used for the synthesis of other AA. Findings reported here demonstrate that there is no renal extraction of glycine from whole blood as observed in rat (23) . Actually, the lack of a glycine extraction by the kidney appears to be the result of an uptake from plasma, as already shown in starved man (17) and in acidotic dog (24) , and of a concomitant addition of similar amounts of glycine to the renal venous blood by way ofblood cells. The origin of glycine added to blood cells within the kidney is obscure. It is known that glycine is a component of glutathione, which is present in high concentrations in erythrocytes and in living cells o 12 (25) . There is also evidence that glutathione turnover is much more rapid in kidney than in any other organ (25) and that, in vitro, glutathione degradation releases glycine within the kidney (26) . Thus, a glutathione breakease by tghet down in the kidney might be an important source ofglys) and in five cine. Glycine so produced might be added to the renal glycine pool and partially transferred to blood cells. (2, 17, 23, 24) . Not more than 50% of such a large amount of serine prodtuced by the kidney can be accouinted for by glycine supplied to the renal glycine pool via plasma, as confirmed by data by other authors (2, 24) . The other 50% of serine must derive from glycine supplied to the kidney by other souirces.
Our results show that in normal man large amounts of citrulline are constantly extracted by the kidney and this extraction is well correlated with the release of arginine (Fig. 1) . This relationship suggests that the humnan kidney produces arginine from citrulline, as already demonstrated in rats both in vitro (27) and in vivo (28) . Thtis, the kidney shares the overall release of arginine with muscular tissue, which prodtuces comparable amouints of arginine (29, 30) . Significantly different from nitrogen extracted, P < 0.025.
Findings obtained in normlal controls demonstrate that the humiian kidney produces significant amiounts of tyrosine. This production is of the saime magnitude as that of musculalr production, as cain be calculated from data by Felig and \Vahren (29, 30) . Though the liver synthesizes large amounts of tyrosine, the net tyrosine balance across the hepatosplanchnic bed demonstrates a significant uptake of this AA (30). Hence in the postabsorptive state the kidney and the muscle participate almuost equally in the release of significant amounts of tyrosine into the circulation. It is believed that tyrosine is produced by the kidney from phenylalanine through the phenylalanine 4-hydroxylase system (EC 1.14.16.1) (31). However, in our cases, the amiount of phenylalanine extracted by the kidney is not sufficient to account for the amount of tyrosine produced.
Finally, an important finding is the renal release of taurine. Since this AA is significantly released into the circulation neither by muscular tissue nor by the hepatosplanchnic bed (6) , it follows that in postabsorptive man the kidney appears to have a major role in homeostasis of circulating taurine. This AA may derive from cysteine, which in turn may derive from glutathione.
Our results demonstrate that chronic renal disease significantly affects both the uptake and the release of the same AA considered above under normal conditions. In addition, total renal production of ammonia, namely that excreted plus that added to renal venous blood, is decreased in relation to the reduction of ftinctioning renal mass. In the same condition, renal glutamine extraction from whole blood is greatly decreased, as already shown by measuring A-RV differences in plasma glutamine (5, 22) . In contrast to normiial subjects, in patients with CRI only 35% of ammonia produced can be accounted for by the amount of glutamine extracted from arterial blood, even assuming that both N groups of glutamine are used for ammonia production. Accordingly, most of the ammonia produced must derive from substrates other than glutamiine extractedl from blood. In CRI the availability of glutamine supplied to the kidney through the arterial inflow does not seem to be rate limiting for ammonia production. In fact glutamine loads, administered orally (32) or intravenously (22) , failed to enhance ammonia excretion in patients with CRI, whereas comparable loads given to normal controls induced a significant increase in ammonia excretion. In patients with CRI, the rate of renal ammonia production per unit ofGFR is increased fourfold. Nevertheless, the rate of glutamine extraction per unit of GFR is not different from controls, despite the presence of chronic metabolic acidosis. These data demonstrate that the residual functioning renal tissue does not extract enough glutamine to account for the amount of ammonia produced. Moreover, if patients with CRI are compared with a group of subjects with normal renal function and NH4C1 induced chronic acidosis, elsewhere reported (5) , it is possible to calculate that ammonia production per unit of GFR is similar in both groups (116.0+20.70 ,umol/min per 100 ml GFR in NH4Cl acidosis vs. 89.2+9.92 in CRI), whereas glutamine extraction per unit of GFR is sevenfold higher in subjects with NH4Cl acidosis (85.2+13.86 ,mol/min per 100 ml GFR in NH4Cl acidosis vs. 12.6±10.62 in CRI, P < 0.001). All the above data strongly suggest that in CRI glutamine was inadequately used by the residual functioning tissue for ammonia production. The defective use might be dependent on an altered transport of glutamine into the mitochondria, the major sites for its use (33) and/or on an inhibition of glutaminases by some "uremic toxin". It has been shown that methylguanidine inhibits rat kidney phosphate-independent glutaminase activity (34) . Further, in rats with subtotal nephrectomy, phosphatedependent glutaminase activity (EC 3.5.1.2.) per gram oftissue is significantly decreased despite an increased production rate of ammonia per residual nephron (35) .
The net balance across the kidney of AA besides glutamine appears to be altered by renal disease. The absolute values of uptake or release of each AA are decreased with the exception of leucine. However, when extraction and production rates of each AA are calculated per unit of GFR, different behaviors are seen.
Thus, alanine release is increased fourfold, citrulline uptake and arginine release are increased threefold compared to those measured in normal controls. Moreover, the relationship between citrulline uptake and arginine release is still present (Fig. 1) , despite the quantitative variations of the net balance of these AA across the kidney. Accordingly, the conversion of citrulline into arginine seems fairly preserved. Likewise, the residual functioning renal tissue adds twice as much tyrosine to the venous blood compared to controls. On the contrary, proline extraction, and serine, threonine, and lysine release per unit of GFR are not different from controls, suggesting a defective nephron adaptation of the metabolism of these AA. A still more severe derangement is observed in the renal metabolism of glycine, taurine, phenylalanine, and ornithine, whose uptake or release disappear.
Data presented in this study suggest that the renal metabolic alterations induced by chronic disease may be responsible for changes of arterial levels of some AA, that were observed in patients with CRI considered here, and previously outlined (5, (36) (37) (38) (39) ). Thus, the lower level of tyrosine in arterial blood in patients with CRI may be accounted for by decreased renal production, as suggested by the relationship between renal tyrosine release and arterial level of this AA (Fig. 2) . The same may be inferred for serine. In addition, the higher arterial level of proline and glutamine may be partly dependent on a reduced use by the diseased kidney. On the contrary, the increased citrulline level measured in the arterial blood ofthese patients is likely not only dependent on the decreased renal uptake of this AA, inasmuch as arterial citrulline level shows a tendency to rise as renal uptake increases.
Striking differences between normal subjects and patients with CRI are revealed if one compares the net balance between the N contributed by AA extracted from the arterial blood, and the N contributed by AA added to the renal veins and by ammonia produced (Table VI) . In CRI the amount of N released is more than twice as much as the amount of N taken up by the kidney. We think that the most reasonable explanation for the excess of N released by the kidney in patients with CRI is an intrarenal degradation of peptides, polypeptides, and low molecular weight proteins supplied to the kidney by the arterial inflow. The renal breakdown of these compounds and the presence in the kidney of specific degrading enzymes are largely supported by the literature (40) . Nitrogen balance across the kidney reported here suggests that the renal breakdown of these substances is increased in CRI. Such a breakdown releases free AA, which may be added to renal vein blood and/or conveyed to various metabolic fates, including ammonia production. The comparison between the rate of ammonia production and the rate of AA extraction in CRI supports such a hypothesis. In fact, the N groups deriving from glutamine and proline extracted from the arterial blood can account for not more than 50% of ammonia produced by the kidney. Citrulline is not included in this calculation because it seems to be used mainly for arginine production and it does not produce ammonia in vitro (unpublished observations), whereas proline may be an ammonia precursor through conversion into glutamate (41) . Therefore, it may be presumed that approximately half of the ammonia produced in CRI derives from precursors made available by protein and peptide degradation within the kidney. Consequently, it seems likely that in CRI glutamine supplied to the kidney by arterial )loo0 isi no longer the mnajor aammllonia precuirsor.
